Gheuens Sarah bought AGIO
October 27, 2025 · Form 4 insider transaction
Gheuens Sarah bought 3,302 shares of Agios Pharmaceuticals, Inc. at $25.01 per share, a transaction worth $82.6K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
3,302
Price
$25.01
Total value
$82.6K
InsiderGheuens Sarah
Role—
SecurityCommon stock
Transaction codeM: Option exercise
Transaction dateOctober 27, 2025
Filing dateOctober 29, 2025
Shares owned after65,029
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Includes 456 shares purchased through the Company's employee stock purchase plan.